OpenResearchAlpha

Journal of Cancer Research and Clinical Oncology · 13 Nov 2026

Association of sex and age on outcomes of maintenance treatment in pati​ents with advanced esophagogastric adenocarcinoma: an exploratory analysis of the randomized AIO-YMO-0111-MATEO trial

G. Stockerh-index 10, R. Stelmach, S. Lorenzen, T. Ettrich, M. Knödler, F. Longo, B. Chibaudel, R. Greil, M. Perwög, J. Larcher-Steiner, S. Held, F. Lordick, G. M. Haag

0
Citations
no database records one yet
0
Citations in 2026
so far
10
Leading author's h-index
G. Stocker, in QAI's scholar index
30
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Purpose Sex and age have an impact on efficacy and toxicity of chemotherapy (ctx) in patients (pts) with esophagogastric adenocarcinoma (EGA). However, data are limited, as clinical trials frequently do not report sex-specific differences and older pts are often underrepresented. Methods MATEO is an international randomized trial, confirming non-inferiority of S-1 maintenance therapy compared to continued platinum-based ctx in pts with advanced EGA without disease progression after 3 months of ctx. Toxicity pattern favored S-1 monotherapy. We conducted a post hoc exploratory analysis to assess the impact of sex and age on treatment outcomes. Results In the per-protocol population, 112 pts (72.7%) were male and 42 (27.3%) were female. 37.7% of pts were ≥ ​70 years. Female pts more often had distal stomach tumors (64.3%), while male pts had more esophagogastric junction tumors (76.7%). In a pooled analysis, female pts showed significantly longer progression-free survival (PFS) (median 9.9 vs. 4.3 months, HR 0.56 [95% CI 0.38–0.83], log-rank: p = 0.0033), and overall survival (OS) (median 14.4 vs. 12.2 months, HR 0.65 [95% CI 0.44–0.97], log-rank: p = 0.0348). No age-related differences in PFS and OS were observed between pts ≥ 70 years and < 70 years. In multivariate analyses, female sex, but not younger age, was associated with a trend towards improved OS. No significant sex- or age-specific differences in terms of toxicity were observed. Conclusion Primary tumor location differed by sex. A trend for superior outcome in female pts was observed, whereas age did not have a significant impact on outcome.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • G. Stocker has the highest h-index among the authors (10).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (13)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (30)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 10 more references

A free account opens the rest of the citing papers and references on every paper’s page.

Association of sex and age on outcomes of maintenance treatment in pati​ents with advanced esophagogastric adenocarcinoma: an exploratory analysis of the randomized AIO-YMO-0111-MATEO trial - QAI OpenResearch